Stereotactic body radiotherapy (SBRT) in combination with surgery for primary and metastatic liver tumors

被引:0
|
作者
Lappinen, Erik
Thai, Ngoc
Tom, Kusum
Khan, Akhtar
Day, Ellen
Green, William Ross
Christensen, James
Kirichenko, Alexander V.
机构
[1] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
[2] Drexel Univ, Coll Med, Pittsburgh, PA USA
关键词
D O I
10.1200/jco.2012.30.4_suppl.347
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
347
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Impact of Stereotactic Body Radiotherapy (SBRT) in Oligoprogressive Metastatic Disease
    Ramadan, S.
    Quan, K.
    Schnarr, K. L.
    Juergens, R.
    Hotte, S. J.
    Kapoor, A.
    Meyers, B. M.
    Swaminath, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E479 - E479
  • [22] Multicenter Results of Stereotactic Body Radiotherapy (SBRT) for Non-Resectable & Non-Transplantable Primary Tumors of the Liver
    Sanabria, J.
    Rojas, D.
    Snyder, L.
    Ibarra, R.
    Singh, D.
    Yao, M.
    Kunos, C.
    Milano, M.
    Katz, A.
    Goodman, K.
    Stephans, K.
    Aucejo, F.
    El-Gazzaz, G.
    Miller, C.
    Fung, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 467 - 468
  • [23] Multicenter Results of Stereotactic Body Radiotherapy (SBRT) for Non-Resectable & Non-Transplantable Primary Tumors of the Liver
    Sanabria, Juan
    Rojas, Daniel
    Snyder, Laura
    Ibarra, Rafael
    Singh, Deepjot
    Yao, Min
    Kunos, Charles
    Milano, Michael
    Katz, Alan
    Goodman, Kathrin
    Stephans, Kevin
    Aucejo, Federico
    El-Gazzaz, Galal
    Miller, Charles
    Fung, John
    LIVER TRANSPLANTATION, 2011, 17 (06) : S158 - S158
  • [24] A phase Ib study of pembrolizumab (Pem) in combination with stereotactic body radiotherapy (SBRT) for resectable liver metastatic colorectal cancer (CRC).
    Turk, Anita Ahmed
    Lubner, Sam Joseph
    Uboha, Nataliya Volodymyrivna
    LoConte, Noelle K.
    Mulkerin, Daniel
    Kim, David H.
    Matkowskyj, Kristina
    Weber, Sharon M.
    Abbott, Daniel
    Eickhoff, Jens C.
    Bassetti, Michael F.
    Deming, Dustin A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [25] Assessment of risk factors for recurrence of primary lung tumors treated with stereotactic body radiotherapy (SBRT).
    Vinagre Perez, I.
    Portilla Quattrociocchi, G.
    Pena Fuentes, A.
    Lavilla, J.
    Astudillo Sarmiento, M.
    Carreres Ortega, Y.
    Nunez Munoz, R.
    Tovar Echeverri, D.
    Fernandez Tercero, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S501 - S501
  • [26] Extracranial stereotactic body radiotherapy. Review of main SBRT features and indications in primary tumors
    Rubio, Carmen
    Morera, Rosa
    Hernando, Ovidio
    Leroy, Thomas
    Lartigau, S. Eric
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2013, 18 (06) : 387 - 396
  • [27] The Combination of Stereotactic Body Radiation Therapy and Immunotherapy in Primary Liver Tumors
    Kreidieh, Malek
    Zeidan, Youssef H.
    Shamseddine, Ali
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [28] Stereotactic radiotherapy (SRT) for primary and metastatic liver tumors with functional treatment planning
    Kirichenko, Alexander V.
    Ngoc Thai
    Lappinen, Erik
    Gayou, Olivier
    Day, Ellen
    Kotinsley, Katherine
    Gott, Susan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [29] Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)
    Li, Xiaomin
    Sun, Yu
    Tang, Liang
    Li, Yan
    Yang, Xiaoqin
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [30] Stereotactic radiotherapy of primary liver tumors and liver metastases
    Bostel, Tilman
    Bremer, Michael
    ONKOLOGE, 2022, 28 (04): : 318 - 325